Brief: Erasca Inc Revolution Medicines Alleges Erasca's Eras-0015 Infringes U.S. Patent No. 12,409,225
27/04/2026 14:10
April 27 (Reuters) - Erasca Inc ERAS.O: ERASCA INC - REVOLUTION MEDICINES ALLEGES ERASCA'S ERAS-0015 INFRINGES U.S. PATENT NO. 12,409,225 - SEC FILING ERASCA INC - REVOLUTION MEDICINES ALLEGES TRADE SECRET MISAPPROPRIATION RELATED TO ERAS-0015 - SEC FILING ERASCA INC - INTENDS TO CONTEST REVOLUTION MEDICINES' ALLEGATIONS - SEC FILING ERASCA INC - REVOLUTION MEDICINES DEMANDS ERASCA CEASE U.S. ACTIVITIES FOR ERAS-0015 AND COMPARATIVE STATEMENTS - SEC FILING Source text: [ID:n0001193125-26-179214] Further company coverage: ERAS.O ((Reuters.Briefs@thomsonreuters.com;))